Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Advancements in Multiple Myeloma Treatment with BELLA
This chapter discusses the novel antibody drug conjugate BELLA, emphasizing its mechanisms, recent study results, and potential benefits in treating multiple myeloma, especially in high-risk patients. It highlights the effectiveness of combination therapies and innovative dosing strategies while addressing associated adverse events.
Transcript
Play full episode
